PATENT CLAIM ANALYSIS

Application Number: 15956936
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-08
Patent Classification: ["424", "078040"]

Abstract:
The invention provides compositions and methods for the treatment of presbyopia. The compositions preferably comprise aceclidine, an alpha-adrenergic agonist, a cryoprotectant and a non-ionic surfactant. The compositions optionally contain a viscosity enhancer.

Claim (Index 2):
The composition of  claim 1 , wherein the cryoprotectant is selected from the group consisting of a polyol, a sugar, an alcohol, a lower alkanol, a lipophilic solvent, a hydrophilic solvent, a bulking agent, a solubilizer, an antioxidant, a cyclodextrin, a maltodextrin, colloidal silicon dioxide, polyvinyl alcohol, glycine, 2-methyl-2,4-pentanediol, cellobiose, gelatin, polyethylene glycol (PEG), dimethyl sulfoxide (DMSO), formamide and antifreeze protein 752.

Metadata:
- Claim Count in Document: 38.0
- Percentile: 91.0
- Lexical Diversity: 1.37037
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15073139', '15073089', '15235431', '14223639', '15864703']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8500705111441581
- 35 USC 102 Novelty (BERT): 0.5963176521271045
- Combined Prediction Score: 0.8246952252424528
- Mean Citation Score: 535.783068
- Max Citation Score: 543.4464
- Similarity Product: 451.0766341112137

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test